{
  "id": 115210,
  "name": "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)",
  "slug": "american-clinical-laboratory-association-acla",
  "state": "DC",
  "description": "Trade association for clinical laboratories",
  "totalSpending": 2010000,
  "filings": 21,
  "yearlySpending": [
    {
      "year": 2020,
      "income": 290000
    },
    {
      "year": 2021,
      "income": 400000
    },
    {
      "year": 2022,
      "income": 780000
    },
    {
      "year": 2023,
      "income": 170000
    },
    {
      "year": 2024,
      "income": 230000
    },
    {
      "year": 2025,
      "income": 140000
    }
  ],
  "firms": [
    "COVINGTON & BURLING LLP"
  ],
  "lobbyists": [
    "SCOTT DANZIS",
    "WILLIAM WICHTERMAN",
    "MUFTIAH MCCARTIN",
    "BRENDAN PARETS",
    "GABRIEL NEVILLE",
    "LAYTH ELHASSANI",
    "ED MCCLELLAN",
    "WADE ACKERMAN",
    "AMY LEISER"
  ],
  "issues": [
    "DIS",
    "HCR",
    "BUD",
    "MED",
    null
  ],
  "sampleDescriptions": [
    "Appropriations funding in response to COVID pandemic; Medicare funding",
    "Appropriations funding in response to COVID pandemic; Medicare funding\n\n(*Brendan Parets did not lobby the U.S. Senate*)",
    "Appropriations funding in response to COVID pandemic; Medicare funding; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128)",
    "Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response.",
    "Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); Coronavirus impact and response.",
    "Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Coronavirus impact and response.",
    "Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Coronavirus impact and response; FDASLA Act of 2022 (S. 4348); Food and Drug Amendments of 2022 (H.R.7667).",
    "Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Consolidated Appropriations Act, 2023 (H.R.2617); Saving Access for Laboratory Services Act (S. 4449/H.R. 8188).",
    "Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation; VALID Act (H.R. 2369)",
    "Discussion of Food and Drug Administration (FDA) policies and authority related to diagnostics and laboratory regulation.",
    "Potential legislation for regulation of laboratory diagnostics; discussion of Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation.",
    "Potential legislation for regulation of laboratory diagnostics."
  ],
  "years": [
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -52,
  "trajectory": "declining",
  "yearsActive": 6,
  "avgAnnualSpending": 335000,
  "peakYear": 2022,
  "lobbyistCount": 9,
  "firmCount": 1,
  "issueCount": 4,
  "industry": "healthcare"
}